semaglutide and cardiovascular outcomes in obesity without diabetes Long-term weight loss effects of in the SELECT trial Full SELECT Results Affirm CV

Clin Pharmacokinet 2017;56:551559 [DOI] [PMC free article] [PubMed] [Google Scholar] 10

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor,sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, doubleblind, non-inferiority trial

Antioxidant Paradox: Clinical trials (SELECT vitamin E, beta-carotene) showed supplements increased cancer rather than preventing it

Skipping dose escalation : Advancing too quickly through the titration schedule or starting at maintenance doses dramatically increases gastrointestinal adverse effects and treatment discontinuation

1,10 incl